arrow
返回
A

Amir Fathi

mass general brig ham cancer institute

13H指数
56论文数
747被引数
收录论文 7
发表时间
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed FLT3-ITD–negative acute myeloid leukemiaQUANTUM-Wild:一项关于Quizartinib在初诊FLT3-ITD阴性急性髓性白血病中的III期随机临床试验
err2026-07-11
err0
errOAAI
errPau Montesinos; Jessica K. Altman; Lars Bullinger; June-Won Cheong; Amir T. Fathi; Mark J. Levis; Selina Luger; Toshihiro Miyamoto; Esther Natalie Oliva; Alexander E. Perl; Christian Récher; Rebeca Rodriquez Veiga; Jianxiang Wang; Amer M. Zeidan; Li Liu; Yvonne Duong; Jaime E. Connolly Rohrbach; Giorgio Inghirami; Karenza Alexis; Andreas Gosberg; Akash Nahar; Kristy Burns; Naval Daver; Harry P. Erba
err分享
err收藏
err分享
err收藏
Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia
errCANCER
IF5.1
err2018-11-13
err26
errOAAI
errBrunner, Andrew M.; Neuberg, Donna S.; Wander, Seth A.; Sadrzadeh, Hossein; Ballen, Karen K.; Amrein, Philip C.; Attar, Eyal; Hobbs, Gabriela S.; Chen, Yi-Bin; Perry, Ashley; Connolly, Christine; Joseph, Christelle; Burke, Meghan; Ramos, Aura; Galinsky, Ilene; Yen, Katharine; Yang, Hua; Straley, Kimberly; Agresta, Sam; Adamia, Sophia; Borger, Darrell R.; Iafrate, Anthony; Graubert, Timothy A.; Stone, Richard M.; Fathi, Amir T.
err分享
err收藏
Biochemical, Epigenetic, and Metabolic Approaches to Target IDH Mutations in Acute Myeloid Leukemia
err2015-07-01
err43
PREAI
errFathi, Amir T.; Wander, Seth A.; Faramand, Rowan; Emadi, Ashkan
err分享
err收藏